Presentation will begin: Wednesday, October 27, 2021 - 11:00 AM EDT
Presented by: Jürgen Popp, Leibniz Institute of Photonic Technology
Jürgen Popp highlights his group's recent efforts in the implementation of multicontrast spectroscopy in combination with AI based analysis methods for an improved clinical diagnosis leading to a personalized therapy. In accordance with the motto "from ideas to the instrument," the focus is on the implementation of multicontrast spectroscopic approaches with a focus on Raman spectroscopy in routine clinical applications. The addressed medical application fields are infectious diseases and cancer, which require new methods of differential diagnosis for early diagnosis and personalized therapy.
About the presenter
Jürgen Popp, Ph.D., holds a chair for physical chemistry at the Friedrich-Schiller University Jena and is also the scientific director of the Leibniz Institute of Photonic Technology, Jena. His research interests are mainly concerned with biophotonics and optical health technologies. He has published more than 800 journal papers and received several awards such as an honorary doctoral degree from Babes-Bolyai University in Cluj-Napoca, Romania, or the prestigious Pittsburgh Spectroscopy Award. In 2016, he was elected to the American Institute for Medical and Biological Engineering College of Fellows. In 2018, Popp was awarded the renowned Ioannes Marcus Marci Medal of the Czechoslovak Spectroscopy Society and won the third prize of the Berthold Leibinger Innovationspreis and the Kaiser-Friedrich-Forschungspreis. In 2019, he won the Ralf-Dahrendorf Award for the European Research Area and the Research Award for Applied Sciences of the Free State of Thuringia, Germany. In 2020, he became an OSA Senior Member.
About the sponsor(s)
- Coherent Inc. - Provider of lasers and laser-based technology for scientific, commercial, and industrial customers.